July 14, 2026 — RNews

#tumor-recurrence — Tuesday, July 14, 2026 (1 items)

hot top new

← prev day next day →

0

Disrupting fumarylacetoacetate hydrolase by stratified nanoplatforms orchestrates metabolic-immune reprogramming and prevents post-ablation HCC relapse. (nature.com)

Hong Z … Ma T Nature Communications 2026-07-14

#immunotherapy #hepatocellular carcinoma #metabolism #nanoparticles #tumor-recurrence